Sun Pharmaceutical Industries Limited (NSEI: SUNPHARMA)
Health Care · Pharmaceuticals · IN
Rs1,781.00
-1.28% today · +7.7% 1Y
Sun Pharmaceutical Industries Limited (NSEI: SUNPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $44.17B and employs 47,000 people.
Over the last twelve months the share price has gained 7.7%, trading between 1.58K and 2.05K.
Tweenvest scores Sun Pharmaceutical Industries Limited across four factors: quality 85/100, value 45/100, growth 53/100, dividend 72/100. Its strongest factor is quality.
SUNPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.17B
- Revenue (TTM)
- $6.34B
- P/E
- 35.34
- EPS
- 50.40
- Dividend yield
- 0.89%
- Beta (5Y)
- 0.14
- 52-week high
- Rs2,046.90
- 52-week low
- Rs1,583.70
- Avg volume (3M)
- —
- Shares outstanding
- 2.40B
- Employees
- 47,000
- Next earnings
- —
About Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
- ISIN
- INE044A01036
- Founded
- 1983
- Listed since
- Jan 1, 1996
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bayer AktiengesellschaftXTRA: BAYN | $46.85B | €42.59 | -3.14% |
| Jiangsu Hengrui Pharmaceuticals Co.,LtdSHSE: 600276 | $46.41B | CN¥47.20 | +3.46% |
| Teva Pharmaceutical Industries LimitedNYSE: TEVA | $45.66B | $39.25 | +0.18% |
| Galderma Group AGSWX: GALD | $45.48B | CHF162.80 | +0.12% |
| UCB SAENXTBR: UCB | $43.49B | €201.80 | -0.98% |
| Haleon plcLSE: HLN | $40.08B | £3.44 | +0.55% |
| Otsuka Holdings Co., Ltd.TSE: 4578 | $38.12B | ¥11,475.00 | +0.17% |
| Sandoz Group AGSWX: SDZ | $35.75B | CHF69.32 | +1.17% |
Figures last refreshed Oct 4, 2026.